Study identifier:BY9010/M1-132
ClinicalTrials.gov identifier:NCT00163358
EudraCT identifier:N/A
CTIS identifier:N/A
Efficacy of ciclesonide and of a fixed combination with fluticasone propionate and salmeterol versus placebo on long-term asthma control
asthma
Phase 3
No
Ciclesonide
All
630
Interventional
12 Years - 75 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Oct 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|